Decipher Labs Limited

COMBDRG

INE643N01012

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:57 28/06/2024 pm IST			5-day change	1st Jan Change
17.83 ^INR	-0.78%		-4.75%	+2.29%

30/04	Decipher Labs Limited Announces Change in Registered Office Address	CI
14/02	Decipher Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Combat Drugs Limited Appoints Sushant Mohan Lal as Compliance Officer

October 30, 2017 at 05:06 pm IST

Combat Drugs Limited at the board meeting held on October 30, 2017 approved Sushant Mohan Lal appointment as Compliance Officer with immediate effect.

Latest news about Decipher Labs Limited

Decipher Labs Limited Announces Change in Registered Office Address	30/04	CI
Decipher Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02	CI
Decipher Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02	CI
Decipher Labs Limited Appoints Gayathri Raghuram as an Independent Director of the Company	30/23/30	CI
Decipher Labs Limited Announces Executive Changes	16/23/16	CI
Decipher Labs Limited Announces the Appointment of Gayathri Raghuram as Additional and Independent Director	04/23/04	CI
Decipher Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/23/14	CI
Decipher Labs Limited Announces Company Secretary and Compliance Officer Changes	19/23/19	CI
Decipher Labs Limited Announces Management Changes	30/23/30	CI
Decipher Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/23/30	CI
Decipher Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/23/30	CI
Decipher Labs Limited Announces Re-Constitution of the Committees	06/23/06	CI
Decipher Labs Limited Announces the Resignation of Mr. Bhupendralal Waghray and Ms. Vemuri Shilpa as Independent Directors of the Company	28/23/28	CI
Decipher Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/22/14	CI
Decipher Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/22/13	CI
Decipher Labs Limited Announces Board Changes	13/22/13	CI
Decipher Labs' Consolidated Net Profit More than Doubles in Fiscal Q4; Shares Jump 5%	18/22/18	MT
Decipher Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	16/22/16	CI
Decipher Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	16/22/16	CI
Decipher Labs Limited Announces Board Changes	30/22/30	CI
Decipher Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14/22/14	CI
Decipher Labs Limited Provides Update on Business Development - Branch Office	01/21/01	CI
Decipher Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	13/21/13	CI
Decipher Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	14/21/14	CI
Decipher Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	28/21/28	CI

Decipher Labs Limited is an India-based company, which is engaged in the manufacture and marketing of pharmaceuticals and allied products and services. It also provides services to the information technology industry. The Company also caters to various formulators, manufacturers and research and development agencies for their bulk needs and sources and supplies various drugs and allied chemicals and allied products and services to the companies upon request. The Company offers a range of services, including technology integration and systems consulting, software development consulting, and management of information technology (IT) projects. The Companyâs wholly owned subsidiaries include ICP Solutions Private Limited and Decipher Software Solutions LLC.

Sector

Pharmaceuticals

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
DECIPHER LABS LIMITED	+2.29%	21.6L
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.76%	4.38TCr
OTSUKA HOLDINGS CO., LTD.	+28.00%	2.28TCr
SANDOZ GROUP AG	+20.25%	1.56TCr
CIPLA LIMITED	+18.82%	1.43TCr
ZYDUS LIFESCIENCES LIMITED	+55.83%	1.3TCr
THE MEDICINES COMPANY	-0.05%	678.76Cr
ONO PHARMACEUTICAL CO., LTD.	-12.70%	641.27Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+14.65%	568.66Cr